Lifecore Biomedical, Inc. Common Stock (NASDAQ: LFCR) last traded at $4.54, up 0.44% on the session. The quote above updates while this page is open; the figures below are drawn from Lifecore Biomedical, Inc. Common Stock’s own filings and are restated only when a new one is published.
Lifecore Biomedical, Inc. Common Stock trades on NASDAQ under the ticker LFCR. Its market capitalisation is $171.85 million.
Valuation measures for Lifecore Biomedical, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $171.85M |
|---|---|
| Enterprise value | $368.02M |
| Price / sales | 1.33 |
| Beta | 0.95 |
Trailing-twelve-month figures tagged in Lifecore Biomedical, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $128.87M |
|---|---|
| Net income (TTM) | -$38.72M |
| EPS (TTM) | -$1.27 |
| Gross margin | 31.27% |
| Operating margin | -13.38% |
| Cash | $17.24M |
Range and volume for LFCR over the past 52 weeks.
| 52-week high | $8.98 |
|---|---|
| 52-week low | $3.63 |
| Volume | 88.5K |
| Average volume | 181.4K |
| Previous close | $4.52 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.